{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T08:59:51Z","timestamp":1793177991966,"version":"4.5.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,21]],"date-time":"2023-03-21T00:00:00Z","timestamp":1679356800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008897","name":"Janssen Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014482","name":"Momenta Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014482","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["AJOG Global Reports"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.xagr.2023.100203","type":"journal-article","created":{"date-parts":[[2023,3,24]],"date-time":"2023-03-24T03:55:40Z","timestamp":1679630140000},"page":"100203","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"title":["Live birth prevalence of hemolytic disease of the fetus and newborn in the United States from 1996 to 2010"],"prefix":"10.1016","volume":"3","author":[{"given":"Devin","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7251-9985","authenticated-orcid":false,"given":"Leona E.","family":"Ling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexis A.","family":"Krumme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"May Lee","family":"Tjoa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Kenneth J.","family":"Moise","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xagr.2023.100203_bib0001","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/vox.12265","article-title":"Haemolytic disease of the fetus and newborn","volume":"109","author":"de Haas","year":"2015","journal-title":"Vox Sang"},{"key":"10.1016\/j.xagr.2023.100203_bib0002","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1097\/AOG.0b013e31826d7dc1","article-title":"Management and prevention of red cell alloimmunization in pregnancy: a systematic review","volume":"120","author":"Moise","year":"2012","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.xagr.2023.100203_bib0003","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1080\/17474086.2017.1331124","article-title":"Neonatal management and outcome in alloimmune hemolytic disease","volume":"10","author":"Ree","year":"2017","journal-title":"Expert Rev Hematol"},{"key":"10.1016\/j.xagr.2023.100203_bib0004","first-page":"484","article-title":"Improving the management and outcome in haemolytic disease of the foetus and newborn","volume":"11","author":"Lopriore","year":"2013","journal-title":"Blood Transfus"},{"key":"10.1016\/j.xagr.2023.100203_bib0005","unstructured":"Calhoun DA, Bahr T. Alloimmune hemolytic disease of the newborn: postnatal diagnosis and management. 2022. Available at:https:\/\/www.uptodate.com\/contents\/postnatal-diagnosis-and-management-of-hemolytic-disease-of-the-fetus-and-newborn. Accessed July 28, 2022."},{"key":"10.1016\/j.xagr.2023.100203_bib0006","doi-asserted-by":"crossref","first-page":"3270","DOI":"10.1001\/jama.1991.03460240066029","article-title":"Epidemiology of Rh hemolytic disease of the newborn in the United States","volume":"265","author":"Ch\u00e1vez","year":"1991","journal-title":"JAMA"},{"key":"10.1016\/j.xagr.2023.100203_bib0007","first-page":"518","article-title":"Survey on the prevention and incidence of haemolytic disease of the newborn in Italy","volume":"11","author":"Bennardello","year":"2013","journal-title":"Blood Transfus"},{"key":"10.1016\/j.xagr.2023.100203_bib0008","first-page":"780","article-title":"The incidence and effects of alloimmunization in pregnancy during the period 2000\u20132013","volume":"77","author":"Jerkovi\u0107 Ragu\u017e","year":"2017","journal-title":"Geburtshilfe Frauenheilkd"},{"key":"10.1016\/j.xagr.2023.100203_bib0009","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1182\/asheducation-2015.1.146","article-title":"Hemolytic disease of the fetus and newborn: managing the mother, fetus, and newborn","volume":"2015","author":"Delaney","year":"2015","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.xagr.2023.100203_bib0010","doi-asserted-by":"crossref","first-page":"283","DOI":"10.2147\/JBM.S214118","article-title":"Prevalence and specificity of clinically significant red cell alloantibodies in pregnant women - a study from a tertiary care hospital in Southeast Michigan","volume":"10","author":"Moinuddin","year":"2019","journal-title":"J Blood Med"},{"key":"10.1016\/j.xagr.2023.100203_bib0011","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.1111\/trf.15987","article-title":"Red blood cell alloimmunization prevalence and hemolytic disease of the fetus and newborn in Israel: a retrospective study","volume":"60","author":"Rahimi-Levene","year":"2020","journal-title":"Transfusion"},{"key":"10.1016\/j.xagr.2023.100203_bib0012","doi-asserted-by":"crossref","first-page":"127","DOI":"10.21307\/immunohematology-2019-134","article-title":"Prevalence of clinically significant red blood cell alloantibodies in pregnant women at a large tertiary-care facility","volume":"29","author":"Smith","year":"2013","journal-title":"Immunohematology"},{"key":"10.1016\/j.xagr.2023.100203_bib0013","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ajog.2015.01.049","article-title":"Hemolytic disease of the fetus and newborn due to multiple maternal antibodies","volume":"213","author":"Markham","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.xagr.2023.100203_bib0014","unstructured":"Centers for Disease Control and Prevention. National Hospital Discharge Survey. 2015. Available at: https:\/\/www.cdc.gov\/nchs\/nhds\/index.htm. Accessed March 14, 2023."},{"key":"10.1016\/j.xagr.2023.100203_bib0015","series-title":"Trends in circumcision for male newborns in U.S. hospitals: 1979\u20132010","author":"Owings","year":"2015"},{"key":"10.1016\/j.xagr.2023.100203_bib0016","first-page":"335","article-title":"Trends in length of stay for hospital deliveries -- United States, 1970-1992","volume":"44","year":"1995","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.xagr.2023.100203_bib0017","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1089\/jwh.2014.4749","article-title":"Differences in preeclampsia rates between African American and Caucasian women: trends from the National Hospital Discharge Survey","volume":"23","author":"Breathett","year":"2014","journal-title":"J Womens Health (Larchmt)"},{"key":"10.1016\/j.xagr.2023.100203_bib0018","first-page":"1","article-title":"National Hospital Discharge Survey: 2007 summary","volume":"29","author":"Hall","year":"2010","journal-title":"Natl Health Stat Report"},{"key":"10.1016\/j.xagr.2023.100203_bib0019","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1111\/j.0041-1132.2003.00632.x","article-title":"Thirty-five years of Rh prophylaxis","volume":"43","author":"Bowman","year":"2003","journal-title":"Transfusion"},{"key":"10.1016\/j.xagr.2023.100203_bib0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/tme.12099","article-title":"Anti-D prophylaxis: past, present and future","volume":"24","author":"de Haas","year":"2014","journal-title":"Transfus Med"},{"key":"10.1016\/j.xagr.2023.100203_bib0021","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1111\/trf.16061","article-title":"Impact of red blood cell alloimmunization on fetal and neonatal outcomes: a single center cohort study","volume":"60","author":"Lieberman","year":"2020","journal-title":"Transfusion"},{"key":"10.1016\/j.xagr.2023.100203_bib0022","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1056\/NEJM197505082921906","article-title":"Prevention of Rh hemolytic disease\u2013ten years\u2019 clinical experience with Rh immune globulin","volume":"292","author":"Freda","year":"1975","journal-title":"N Engl J Med"},{"key":"10.1016\/j.xagr.2023.100203_bib0023","first-page":"63","article-title":"ACOG Practice Bulletin. Prevention of Rh D alloimmunization. Number 4, May 1999 (replaces educational bulletin Number 147, October 1990). Clinical management guidelines for obstetrician-gynecologists. American College of Obstetrics and Gynecology","volume":"66","year":"1999","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.xagr.2023.100203_bib0024","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1111\/j.1537-2995.2009.02493.x","article-title":"Advances in red blood cell immunology 1960 to 2009","volume":"50","author":"Garratty","year":"2010","journal-title":"Transfusion"},{"key":"10.1016\/j.xagr.2023.100203_bib0025","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/trf.15635","article-title":"Rhesus D alloimmunization in pregnancy from 1996 to 2015 in Iceland: a nation-wide population study prior to routine antenatal anti-D prophylaxis","volume":"60","author":"Gudlaugsson","year":"2020","journal-title":"Transfusion"},{"key":"10.1016\/j.xagr.2023.100203_bib0026","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/trf.15631","article-title":"Diagnostic value of laboratory monitoring to predict severe hemolytic disease of the fetus and newborn in non-D and non-K-alloimmunized pregnancies","volume":"60","author":"Koelewijn","year":"2020","journal-title":"Transfusion"},{"key":"10.1016\/j.xagr.2023.100203_bib0027","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/tme.12063","article-title":"Alloimmunisation during pregnancy in Greece: need for nationwide HDFN prevention programme","volume":"23","author":"Foudoulaki-Paparizos","year":"2013","journal-title":"Transfus Med"},{"key":"10.1016\/j.xagr.2023.100203_bib0028","doi-asserted-by":"crossref","first-page":"854","DOI":"10.2105\/AJPH.66.9.854","article-title":"Racial difference in incidence of ABO hemolytic disease","volume":"66","author":"Bucher","year":"1976","journal-title":"Am J Public Health"},{"key":"10.1016\/j.xagr.2023.100203_bib0029","doi-asserted-by":"crossref","first-page":"e57","DOI":"10.1097\/AOG.0000000000002232","article-title":"Practice Bulletin No. 181: prevention of Rh D alloimmunization","volume":"130","year":"2017","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.xagr.2023.100203_bib0030","unstructured":"National Center for Health Statistics. National Hospital Discharge Survey, 1996\u20132010. 2015. Available at: https:\/\/www.cdc.gov\/nchs\/nhds\/about_nhds.htm.htm. Accessed August 24, 2022."},{"key":"10.1016\/j.xagr.2023.100203_bib0031","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s10995-007-0255-7","article-title":"Primary cesarean deliveries prior to labor in the United States, 1979\u20132004","volume":"12","author":"Joesch","year":"2008","journal-title":"Matern Child Health J"},{"key":"10.1016\/j.xagr.2023.100203_bib0032","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s12325-010-0106-6","article-title":"Trends in chronologic age and infant respiratory syncytial virus hospitalization: an 8-year cohort study","volume":"28","author":"Fryzek","year":"2011","journal-title":"Adv Ther"},{"key":"10.1016\/j.xagr.2023.100203_bib0033","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/birt.12411","article-title":"Trends and state variations in out-of-hospital births in the United States, 2004-2017","volume":"46","author":"MacDorman","year":"2019","journal-title":"Birth"},{"key":"10.1016\/j.xagr.2023.100203_bib0034","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1002\/bdra.20291","article-title":"Feasibility of using the National Hospital Discharge Survey to estimate the prevalence of selected birth defects","volume":"76","author":"Boulet","year":"2006","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"key":"10.1016\/j.xagr.2023.100203_bib0035","first-page":"1","article-title":"Cause-of-death data from the fetal death file, 2015\u20132017","volume":"69","author":"Hoyert","year":"2020","journal-title":"Natl Vital Stat Rep"}],"container-title":["AJOG Global Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666577823000448?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666577823000448?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T02:22:30Z","timestamp":1763000550000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666577823000448"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["S2666577823000448"],"URL":"https:\/\/doi.org\/10.1016\/j.xagr.2023.100203","relation":{},"ISSN":["2666-5778"],"issn-type":[{"value":"2666-5778","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Live birth prevalence of hemolytic disease of the fetus and newborn in the United States from 1996 to 2010","name":"articletitle","label":"Article Title"},{"value":"AJOG Global Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xagr.2023.100203","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100203"}}